Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |